December 27, 2025
London, UK

Gemini GEMI Soars After CFTC Aproval for Prediction Markets

Gemini GEMI trades 16% higher after Gemini’s affiliate, Gemini Titan, received a Designated Contract Market (DCM) license from the CFTC. This approval after five-year review process that began in March 2020, allows Gemini to legally offer prediction markets—essentially yes/no event contracts on outcomes like elections, economic data, or sports—to U.S. users competing with platforms like Kalshi and Polymarket. Trading will initially launch on the web with USD settlements, with mobile support to follow.

Prediction markets are exploding as a $95 billion opportunity by 2035 (46% CAGR), driven by platforms like Polymarket ($20B+ volume projected for 2025) and Kalshi ($5.8B monthly notional in November). Gemini’s entry to the new market will intensify competition in an industry blending crypto speed with traditional derivatives legitimacy, potentially attracting institutional investors for hedging and probability forecasting (e.g., 91-95% accuracy on event outcomes).

The license paves the way for Gemini GEMI to expand into regulated crypto futures, options, and perpetuals (perps). This aligns with a wave of U.S. regulatory tailwinds for crypto firms in 2025, including other recent IPOs like Circle (CRCL) and Bullish (BLSH).

“Prediction markets have the potential to be as big or bigger than traditional capital markets. Acting Chairman Pham understands this vision and its importance,” said Cameron Winklevoss, Gemini’s President. ”Unlike her predecessor, Acting Chairman Pham has positioned the CFTC as a pro business, pro innovation regulator that will allow America to lead in these new and exciting markets.”

Gemini made its debut on the stock exchange in September with an initial offering price of $28 a share. The GEMI stock 12-month trading range is from $9.67 to $45.89. Gemini has $21B in assets under custody, 1.6M long-term users, and 587K monthly traders. Adding prediction markets could diversify the revenue stream.

Previous Article

Here is Why Enveric Biosciences ENVB Rallies Today

Next Article

Why Axil Brands AXIL Rallies Today

You might be interested in …

PLTR Palantir ORACLE

Palantir (PLTR) Third Quarter Earnings

Palantir Technologies Inc. (PLTR) reported third-quarter earnings, which ended September 30th. The earnings came lower than estimates while the revenue came slightly better than the analyst’s expectations.